Schering Reinspection Brings New FDA-483s: Firm Updates Compliance Plans
Executive Summary
FDA has issued FDA-483 reports to Schering-Plough following recent reinspections of its manufacturing operations in Puerto Rico and New Jersey, the company disclosed June 22.
You may also be interested in...
Schering GMP Work Plan Is One-Third Complete; Toughest Battles Lie Ahead
The remaining two-thirds of Schering-Plough's GMP work plan contain the most challenging requirements under the company's 2002 manufacturing consent decree, CEO Fred Hassan told analysts Nov. 18
Schering Global Manufacturing Head Boisclair Is 30-Year Merck Veteran
Schering-Plough is turning to its Zetia partner Merck for its new head of global manufacturing, Robert Boisclair
Schering Global Manufacturing Head Boisclair Is 30-Year Merck Veteran
Schering-Plough is turning to its Zetia partner Merck for its new head of global manufacturing, Robert Boisclair